Tips for tackling medium-throughput analysis

Read between the lines when you get price points Often, companies will tell you you're paying $0.10 per sample, but "you can't just go off their numbers. You have to really cost it out," says Jeanette Papp, director of the UCLA Genotyping and Sequencing Core Facility. Some companies will sell enough primer for 4,000 samples even if you don't need it. Anticipate the sample quality and whether you

Written byKelly Rae Chi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Often, companies will tell you you're paying $0.10 per sample, but "you can't just go off their numbers. You have to really cost it out," says Jeanette Papp, director of the UCLA Genotyping and Sequencing Core Facility. Some companies will sell enough primer for 4,000 samples even if you don't need it. Anticipate the sample quality and whether you need to rerun the samples, a factor that companies don't account for.

The decision on how you're going to genotype SNPs will change based on how many you have. The window between 30 SNPs and 300 can be tricky because it's not entirely clear what platform you should be using, says Peter Zandi. Sequenom instruments can work in that range, but users must do the cost comparison, he adds.

"You need to make sure you have the power to be able to answer your question before you ask it," says Seth ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo